IGFBP2 and central nervous system cancer: By identifying differentially expressed genes (DEGs) between subtypes, we constructed a four-gene prognostic signature (MAOB, IGFBP2, SERPINA1, and LGR6) and validated its robustness using the Chinese Glioma Genome Atlas (CGGA) expression dataset.